heptakis(2,6-o-dimethyl)beta-cyclodextrin has been researched along with glucose, (beta-d)-isomer in 1 studies
| Studies (heptakis(2,6-o-dimethyl)beta-cyclodextrin) | Trials (heptakis(2,6-o-dimethyl)beta-cyclodextrin) | Recent Studies (post-2010) (heptakis(2,6-o-dimethyl)beta-cyclodextrin) | Studies (glucose, (beta-d)-isomer) | Trials (glucose, (beta-d)-isomer) | Recent Studies (post-2010) (glucose, (beta-d)-isomer) |
|---|---|---|---|---|---|
| 148 | 0 | 45 | 21,956 | 883 | 10,747 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahsan, F; Arnold, JJ; Meezan, E; Pillion, DJ | 1 |
1 other study(ies) available for heptakis(2,6-o-dimethyl)beta-cyclodextrin and glucose, (beta-d)-isomer
| Article | Year |
|---|---|
Mutual inhibition of the insulin absorption-enhancing properties of dodecylmaltoside and dimethyl-beta-cyclodextrin following nasal administration.
Topics: Absorption; Administration, Intranasal; Animals; Area Under Curve; beta-Cyclodextrins; Blood Glucose; Cyclodextrins; Excipients; Glucosides; Hypoglycemic Agents; Insulin; Male; Nasal Mucosa; Rats; Rats, Sprague-Dawley; Surface-Active Agents | 2001 |